What is it about?
Case based discussion on pharmacological management of a pregnant women presenting with hyperemesis and potential urinary tract infection. Consideration of suitable pharmacotherapy for these conditions, use of off-label medications, and teratogenicity of prescribed medications in early pregnancy. Importance of shared decision making and risk versus benefit of prescribing in pregnancy.
Featured Image
Photo by Anastasiia Chepinska on Unsplash
Why is it important?
There is an increasing use of pharmacological treatments for pregnant women as this population now present at an older age, with co-morbidities and at greater risk of developing pregnancy associated conditions such as gestational diabetes and hypertension. Concurrently, the role of the midwife is expanding to include independent prescribing and advanced level practice. As an autonomous practitioner midwives can now undertake whole care episodes for women and neonates , including independent prescribing, and need to be adequately prepared for this expanded role.
Perspectives
This publication is based on a student case study from an independent prescribing final assessment.
Dr Sonya MacVicar
Edinburgh Napier University
Read the Original
This page is a summary of: Prescribing considerations in midwifery practice, Journal of Prescribing Practice, June 2025, Mark Allen Group,
DOI: 10.12968/jprp.2024.0023.
You can read the full text:
Contributors
The following have contributed to this page







